Comparative Study of NXL104/Ceftazidime Versus Comparator in Adults With Complicated Urinary Tract Infections

NCT00690378 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

137

Enrollment

INDUSTRY

Sponsor class

Conditions

Complicated Urinary Tract Infection

Interventions

DRUG: NXL104/ceftazidime
DRUG: Imipenem/Cilastatin

Sponsor

Pfizer